← All investors

Rock Springs Capital
50 portfolio companies · 3 on the map · $1.3B raised · 3 cities
Portfolio map
3 Rock Springs Capital portfolio companies on the map.
Portfolio companies

Imperative Care
Campbell
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Medical Equipment Manufacturing$659MEst. 2015
DELFI Diagnostics
Palo Alto
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Medical and Diagnostic Laboratories$364.8MEst. 2019
Genesis Molecular AI
Burlingame
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Biotechnology Research$296.1M
More portfolio companies
46 more Rock Springs Capital investments we track beyond the map — 50 tracked in total.
HonorConcord · Series E
Vigil NeuroscienceCambridge · Series B
Biomea FusionRedwood City · Series A
Latigo BiotherapeuticsThousand Oaks · Series B
Crinetics PharmaceuticalsSan Diego · Post-IPO Equity
Acumen PharmaceuticalsCarmel · Series B
Gossamer BioSan Diego · Post-IPO Equity
Treeline BiosciencesWatertown · Series A
MOMA TherapeuticsCambridge · Series B
Everest MedicinesNew York · Series C
Innovent BiologicsSuzhou · Series E
CinCor PharmaCincinnati · Series B
Enliven TherapeuticsBoulder · Post-IPO Equity
Xilio TherapeuticsWaltham · Post-IPO Equity
ArsenalBioSouth San Francisco · Series C
Sagimet BiosciencesSan Mateo · Venture
SynthekineMenlo Park · Series B
Zai LabShanghai · Series C
BeiGeneCambridge · Series B
Spruce BiosciencesSouth San Francisco · Post-IPO Equity
City TherapeuticsCambridge · Series A
AffinivaxCambridge · Series C
Ascendis PharmaPalo Alto · Series D
Simcha TherapeuticsNew Haven · Series B
Galera TherapeuticsMalvern · Series C
Vets First ChoicePortland · Private Equity
BraeburnPlymouth Meeting · Debt Financing
Adaptive BiotechnologiesSeattle · Series F
dMedShanghai · Series C
Theseus PharmaceuticalsNew York · Series B
Cullinan TherapeuticsCambridge · Post-IPO Equity
Akero TherapeuticsCambridge · Post-IPO Equity
ClinipaceMorrisville · Series C
Fusion PharmaceuticalsHamilton · Series B
PulmonxRedwood City · Series H
DermiraMenlo Park · Series C
Ra PharmaceuticalsCambridge · Series B
Aeglea BioTherapeuticsAustin · Series B
Chinook TherapeuticsVancouver · Post-IPO Equity
Homology MedicinesLexington · Series B
Clearside BiomedicalAlpharetta · Series C
Proteostasis TherapeuticsCambridge · Series B
ImaraCambridge · Series B
ChiasmaNeedham · Series E
Atea PharmaceuticalsBoston · Series D
Advanced Accelerator ApplicationsSaint-genis-pouilly · Venture
Portfolio map
3 Rock Springs Capital portfolio companies on the map.